Skip to main page content

Retina I

3:15 PM, Saturday 26 Jun 2021 (1 hour 30 minutes)
Learning Objectives
At the end of this session, participants will be able to:
  • Describe new therapeutic options for the treatment of neovascular macular degeneration
  • Integrate key aspects of the evaluation of posterior uveitis
  • Optimize management of submacular hemorrhage
CanMEDS Roles: Medical Expert, Scholar
Scientific Planning Committee Chair - Co-Developed Symposium
Keynote speaker
Keynote Speaker
2023 Planning Committee - Retina

Sub Sessions

Session detail
Allows attendees to send short textual feedback to the organizer for a session. This is only sent to the organizer and not the speakers.
To respect data privacy rules, this option only displays profiles of attendees who have chosen to share their profile information publicly.

Changes here will affect all session detail pages